Search for: "Cal Development Corp" Results 61 - 80 of 702
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jul 2022, 2:59 pm by Kevin LaCroix
There is typically one corrective disclosure—a negative clinical-trial or other FDA-approval development—so under loss-causation law, they can only be about that one thing. [read post]
17 Jul 2022, 9:05 pm by Stephen M. Bainbridge
First, Delaware law provides a well-developed body of high-quality law. [read post]
19 Jun 2022, 4:44 pm by admin
Differential Etiologies So what happens when the plaintiff is claiming that he has developed a disease of ordinary life, one that has multiple known causes? [read post]
Although it has only been a little over a year since nonfungible tokens came into the mainstream, the industry has taken a number of twists and turns, not the least of which is the granting of certain commercial exploitation rights in the digital works associated with an NFT. [read post]
4 May 2022, 3:37 pm
RRL Corp. (2001) 26 Cal.4th 261, 270 (Donovan) [“An essential element of any contract is the consent of the parties. [read post]
19 Mar 2022, 2:09 pm by admin
The FDA acknowledges, for instance, that the acceptable intake is set to mark “a small theoretical increase in risk,” and a “highly hypothetical concept that should not be regarded as a realistic indication of the actual risk,” and thus not an actual risk.[9] The corresponding hypothetical or theoretical risk to the acceptable intake level is clearly small when compared with the human’s lifetime probability of developing cancer (which the FDA states is greater… [read post]